Swaruparani V Gullapalli Md Asheboro, NC - 27203

Swaruparani V Gullapalli Md is categorized under Physicians Offices in Asheboro, NC and active since 2007.

Swaruparani V Gullapalli Md was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Swaruparani Gullapalli at the company’s single location by writing to 547 North Fayetteville St, Asheboro, North Carolina NC 27203 or by phoning (336) 629-7112. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Swaruparani V Gullapalli Md
Contact Person: Swaruparani Gullapalli
Address: 547 North Fayetteville St, Asheboro, North Carolina 27203
Phone Number: (336) 629-7112
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Swaruparani V Gullapalli Md was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Swaruparani Gullapalli for inquiries that concern Swaruparani V Gullapalli Md by calling the company number (336) 629-7112, as your correspondence is most welcome. Additionally, the physical location of the single location of Swaruparani V Gullapalli Md can be found at the coordinates 35.714532,-79.811766 as well as the street address 547 North Fayetteville St in Asheboro, North Carolina 27203.

For its online presence, you may visit Swaruparani V Gullapalli Md’s website at and engage with its social media outlets through on Twitter and on Facebook.